Proteomics-based identification of DEAD-box protein 48 as a novel autoantigen, a prospective serum marker for pancreatic cancer
- 10 March 2005
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 330 (2), 526-532
- https://doi.org/10.1016/j.bbrc.2005.02.181
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Proteomic analysis of interleukin 6-induced differentiation in mouse myeloid leukemia cellsThe International Journal of Biochemistry & Cell Biology, 2004
- An Autoantibody-Mediated Immune Response to Calreticulin Isoforms in Pancreatic CancerCancer Research, 2004
- Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast CancerCancer Research, 2004
- Circulating anti‐MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancerInternational Journal of Cancer, 2002
- Autoantibodies in sera of pancreatic cancer patients identify recombination factor Rad51 as a tumour-associated antigenZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- A Human Common Nuclear Matrix Protein Homologous to Eukaryotic Translation Initiation Factor 4ABiochemical and Biophysical Research Communications, 2000
- Diversity of antinucelar antibody responses in hepatocellular carcinomaJournal of Hepatology, 1997
- p53 Autoantibodies in Patients with Pancreatitis and Pancreatic CarcinomaPancreas, 1996
- Autoantibodies against insulin and β-islet cells in pancreatic adenocarcinoma: A possible explanation for diabetes mellitusInternational Journal of Cancer, 1996
- Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma.JCI Insight, 1993